Icon (ICLR) Other Gross PPE : $265 Mil (As of Dec. 2024)

View and export this data going back to 1998. Start your Free Trial

What is Icon Other Gross PPE?

Icon's Other Gross PPE for the quarter that ended in Dec. 2024 was $265 Mil.

Icon's quarterly Other Gross PPE increased from Jun. 2024 ($504 Mil) to Sep. 2024 ($523 Mil) but then declined from Sep. 2024 ($523 Mil) to Dec. 2024 ($265 Mil).

Icon's annual Other Gross PPE declined from Dec. 2022 ($279 Mil) to Dec. 2023 ($252 Mil) but then increased from Dec. 2023 ($252 Mil) to Dec. 2024 ($265 Mil).

Icon Other Gross PPE Historical Data

The historical data trend for Icon's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Icon Other Gross PPE Chart

Icon Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Gross PPE

Get a 7-Day Free Trial

161.39

297.46

278.95

251.55

264.75

Icon Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Gross PPE	Get a 7-Day Free Trial															251.55	512.92	503.63	522.68	264.75

Icon Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Icon Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Icon PLC (NAS:ICLR) » Definitions » Other Gross PPE

Comparable Companies

Traded in Other Exchanges

IJF:Germany IJF:Germany

Address

South County Business Park, Leopardstown, Dublin, IRL, D18 X5R3

Website

https://www.iconplc.com

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.